Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (24)
Natasha Pillay-Smiley, Jonathan S. Fletcher, Peter de Blank & Nancy Ratner. (2023) Shedding New Light. Pediatric Clinics of North America 70:5, pages 937-950.
Crossref
Crossref
Raquel Caroline Ferreira Lopes Fontanelli, Marcelo de Melo Aragão, Ricardo Silva Pinho & Daniela Gil. (2023) Benefits of intervention in the Central Auditory Nervous System in individuals with Neurofibromatosis Type 1. International Journal of Pediatric Otorhinolaryngology 172, pages 111692.
Crossref
Crossref
Natasha Pillay-Smiley, James Leach, Adam Lane, Trent Hummel, Jason Fangusaro & Peter de Blank. (2023) Evaluating Focal Areas of Signal Intensity (FASI) in Children with Neurofibromatosis Type-1 (NF1) Treated with Selumetinib on Pediatric Brain Tumor Consortium (PBTC)-029B. Cancers 15:7, pages 2109.
Crossref
Crossref
Daniela Angelova-Toshkina, Josua A. Decker, Thomas Traunwieser, Johannes Holzapfel, Stefanie Bette, Simon Huber, Mareike Schimmel, Kurt Vollert, Brigitte Bison, Thomas Kröncke, Nuria C. Bramswig, Dagmar Wieczorek, Astrid K. Gnekow, Michael C. Frühwald & Michaela Kuhlen. (2023) Comprehensive neurological evaluation of a cohort of patients with neurofibromatosis type 1 from a single institution. European Journal of Paediatric Neurology 43, pages 52-61.
Crossref
Crossref
Sulaman Durrani, William Mualem, Ali Shoushtari, Karim Rizwan Nathani & Mohamad Bydon. (2022) Mapping the Landscape of Neurofibromatosis: A Bibliometric Evaluation Highlighting Our Current Understanding, Emerging Therapies, and Global Research Trends. World Neurosurgery 167, pages e1345-e1353.
Crossref
Crossref
Danique M. J. Hellebrekers, Sandra A. M. van Abeelen, Coriene E. Catsman, Sander M. J. van Kuijk, Annick M. Laridon, Sylvia Klinkenberg, Jos G. M. Hendriksen & Johan S. H. Vles. (2022) Cognitive and behavioral functioning in two neurogenetic disorders; how different are these aspects in Duchenne muscular dystrophy and Neurofibromatosis type 1?. PLOS ONE 17:10, pages e0275803.
Crossref
Crossref
Lamiaa Hamie, Edward Eid, Joanna Khalil, Rayah Touma Sawaya, Ossama Abbas & Mazen Kurban. (2022) Genodermatoses with behavioural sequelae. Postgraduate Medical Journal 98:1164, pages 799-810.
Crossref
Crossref
Jody Fromm Longo & Steven L. Carroll. 2022. RAS: Past, Present, and Future. RAS: Past, Present, and Future
305
341
.
Dilek Hacer Cesme, Sinem Aydin, Alpay Alkan, Mehmet Ali Gultekin, Abdusselim Adil Peker, Mekiya Filiz Toprak & Akin Iscan. (2021) Importance of Thalamostriatal Pathway Associated With Neurocognitive Dysfunctions in Children With Neurofibromatosis Type 1: Diffusion Tensor Imaging Findings. Journal of Computer Assisted Tomography 45:2, pages 294-299.
Crossref
Crossref
Sumit Sinha, Nishant Yagnick & Harsh Deora. 2021. Diagnostic Assessment and Treatment of Peripheral Nerve Tumors. Diagnostic Assessment and Treatment of Peripheral Nerve Tumors
313
330
.
James W. Varni, Kavitha Nutakki & Nancy L. Swigonski. (2020) Cognitive functioning and pain interference mediate pain predictive effects on health-related quality of life in pediatric patients with Neurofibromatosis Type 1. European Journal of Paediatric Neurology 28, pages 64-69.
Crossref
Crossref
Jessica A. Kaczorowski, Taylor F. Smith, Amanda M. Shrewsbury, Leah R. Thomas, Valerie S. Knopik & Maria T. Acosta. (2020) Neurofibromatosis Type 1 Implicates Ras Pathways in the Genetic Architecture of Neurodevelopmental Disorders. Behavior Genetics 50:4, pages 191-202.
Crossref
Crossref
Thomas Traunwieser, Daniela Kandels, Franz Pauls, Torsten Pietsch, Monika Warmuth-Metz, Brigitte Bison, Juergen Krauss, Rolf-Dieter Kortmann, Beate Timmermann, Ulrich-Wilhelm Thomale, Peggy Luettich, Anne Neumann-Holbeck, Tanja Tischler, Pablo Hernáiz Driever, Olaf Witt & Astrid K Gnekow. (2020) Long-term cognitive deficits in pediatric low-grade glioma (LGG) survivors reflect pretreatment conditions—report from the German LGG studies. Neuro-Oncology Advances 2:1.
Crossref
Crossref
Eungu Kang, Yoon-Myung Kim, Go Hun Seo, Arum Oh, Hee Mang Yoon, Young-Shin Ra, Eun Key Kim, Heyry Kim, Sun-Hee Heo, Gu-Hwan Kim, Mark J. Osborn, Jakub Tolar, Han-Wook Yoo & Beom Hee Lee. (2019) Phenotype categorization of neurofibromatosis type I and correlation to NF1 mutation types. Journal of Human Genetics 65:2, pages 79-89.
Crossref
Crossref
Federico Nemmi, Fabien Cignetti, Christine Assaiante, Stephanie Maziero, Fredrique Audic, Patrice Péran & Yves Chaix. (2019) Discriminating between neurofibromatosis‐1 and typically developing children by means of multimodal MRI and multivariate analyses. Human Brain Mapping 40:12, pages 3508-3521.
Crossref
Crossref
E. Vaucheret Paz, A. López Ballent, C. Puga, M.J. García Basalo, F. Baliarda, C. Ekonen, R. Ilari & G. Agosta. (2019) Cognitive profile and disorders affecting higher brain functions in paediatric patients with neurofibromatosis type 1. Neurología (English Edition) 34:6, pages 353-359.
Crossref
Crossref
E. Vaucheret Paz, A. López Ballent, C. Puga, M.J. García Basalo, F. Baliarda, C. Ekonen, R. Ilari & G. Agosta. (2019) Pacientes con neurofibromatosis tipo 1: perfil cognitivo y trastornos en funciones cerebrales superiores en la edad pediátrica. Neurología 34:6, pages 353-359.
Crossref
Crossref
James W. Varni, Kavitha Nutakki & Nancy L. Swigonski. (2018) Pain, skin sensations symptoms, and cognitive functioning predictors of health-related quality of life in pediatric patients with Neurofibromatosis Type 1. Quality of Life Research 28:4, pages 1047-1052.
Crossref
Crossref
Jody F. Longo, Shannon M. Weber, Brittany P. Turner-Ivey & Steven L. Carroll. (2018) Recent Advances in the Diagnosis and Pathogenesis of Neurofibromatosis Type 1 (NF1)-associated Peripheral Nervous System Neoplasms. Advances in Anatomic Pathology 25:5, pages 353-368.
Crossref
Crossref
A. Parmeggiani, F. Boiani, S. Capponi, M. Duca, M. Angotti, V. Pignataro, L. Sacrato, L. Spinardi, G. Vara, L. Maltoni, I. Cecconi, M. Pastore Trossello & E. Franzoni. (2018) Neuropsychological profile in Italian children with neurofibromatosis type 1 (NF1) and their relationships with neuroradiological data: Preliminary results. European Journal of Paediatric Neurology 22:5, pages 822-830.
Crossref
Crossref
Anita K. Chisholm, Vicki A. Anderson, Natalie A. Pride, Stephanie Malarbi, Kathryn N. North & Jonathan M. Payne. (2018) Social Function and Autism Spectrum Disorder in Children and Adults with Neurofibromatosis Type 1: a Systematic Review and Meta-Analysis. Neuropsychology Review 28:3, pages 317-340.
Crossref
Crossref
Martha Milade Torres Nupan, Alberto Velez Van Meerbeke, Claudia Alejandra López Cabra & Paula Marcela Herrera Gomez. (2017) Cognitive and Behavioral Disorders in Children with Neurofibromatosis Type 1. Frontiers in Pediatrics 5.
Crossref
Crossref
Yuliya N. Yoncheva, Kristina K. Hardy, Daniel J. Lurie, Krishna Somandepalli, Lanbo Yang, Gilbert Vezina, Nadja Kadom, Roger J. Packer, Michael P. Milham, F. Xavier Castellanos & Maria T. Acosta. (2017) Computerized cognitive training for children with neurofibromatosis type 1: A pilot resting-state fMRI study. Psychiatry Research: Neuroimaging 266, pages 53-58.
Crossref
Crossref
Carl Ernst. (2016) Proliferation and Differentiation Deficits are a Major Convergence Point for Neurodevelopmental Disorders. Trends in Neurosciences 39:5, pages 290-299.
Crossref
Crossref